다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Human gene therapy, v.11 no.18, 2000년, pp.2445 - 2452
Kershaw, Michael H. (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892) , Westwood, Jennifer A. (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892) , Zhu, Zhenping (Department of Molecular and Cell Biology, ImClone Systems, New York, NY 10014) , Witte, Larry (Department of Molecular and Cell Biology, ImClone Systems, New York, NY 10014) , Libutti, Steven K. (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892) , Hwu, Patrick (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892)
AI-Helper
The destruction of newly forming tumor vasculature is a promising approach to inhibit tumor growth. The goal of the present study was to investigate whether human lymphocytes gene modified to express a chimeric receptor specific for the angiogenic endothelial cell receptor, KDR, could react against ...
Aiello, L P, Pierce, E A, Foley, E D, Takagi, H, Chen, H, Riddle, L, Ferrara, N, King, G L, Smith, L E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.. Proceedings of the National Academy of Sciences of the United States of America, vol.92, no.23, 10457-10461.
Baggiolini, Marco, Dewald, Beatrice, Moser, Bernhard. HUMAN CHEMOKINES:An Update. Annual review of immunology, vol.15, 675-705.
Baldwin, Gayle Cocita. The biology of granulocyte-macrophage colony-stimulating factor: Effects on hematopoietic and nonhematopoietic cells. Developmental biology, vol.151, no.2, 352-367.
Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. The Journal of experimental medicine, vol.173, no.3, 647-658.
Am. J. Pathol. BROWN L.F. 1255 143 1993
Cancer Res. BROWN L.F. 4727 53 1993
Brown, Lawrence F, Berse, Brygida, Jackman, Robert W, Tognazzi, Kathi, Guidi, Anthony J, Dvorak, Harold F, Senger, Donald R, Connolly, James L, Schnitt, Stuart J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human pathology, vol.26, no.1, 86-91.
Daly, Tom, Royal, Richard E, Kershaw, Michael H, Treisman, Jonathan, Wang, Gang, Li, Weiping, Herlyn, Dorothee, Eshhar, Zelig, Hwu, Patrick. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene. Cancer gene therapy, vol.7, no.2, 284-291.
de Vries, C, Escobedo, JA, Ueno, H, Houck, K, Ferrara, N, Williams, LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, vol.255, no.5047, 989-991.
Ergün, S, Kiliç, N, Fiedler, W, Mukhopadhyay, A.K. Vascular endothelial growth factor and its receptors in normal human testicular tissue. Molecular and cellular endocrinology, vol.131, no.1, 9-20.
Guerrin, Marina, Moukadiri, Hafida, Chollet, Pascale, Moro, Fraņoise, Dutt, Kamla, Malecaze, Fraņois, Plouët, Jean. Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitro. Journal of cellular physiology, vol.164, no.2, 385-394.
Hanahan, Douglas, Folkman, Judah. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis. Cell, vol.86, no.3, 353-364.
Holliger, P, Prospero, T, Winter, G. "Diabodies": small bivalent and bispecific antibody fragments.. Proceedings of the National Academy of Sciences of the United States of America, vol.90, no.14, 6444-6448.
Cancer Res. HWU P. 3369 55 1995
10.1016/S0065-2776(08)60623-9
Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, vol.362, no.6423, 841-844.
Krüssel, J S, Casañ, E M, Raga, F, Hirchenhain, J, Wen, Y, Huang, H Y, Bielfeld, P, Polan, M L. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium.. Molecular human reproduction, vol.5, no.5, 452-458.
Lin, Pengnian, Buxton, Jake A., Acheson, Ann, Radziejewski, Czeslaw, Maisonpierre, Peter C., Yancopoulos, George D., Channon, Keith M., Hale, Laura P., Dewhirst, Mark W., George, Samuel E., Peters, Kevin G.. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proceedings of the National Academy of Sciences of the United States of America, vol.95, no.15, 8829-8834.
Lu, Dan, Kotanides, Helen, Jimenez, Xenia, Zhou, Qinwei, Persaud, Kris, Bohlen, Peter, Witte, Larry, Zhu, Zhenping. Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2. Journal of immunological methods, vol.230, no.1, 159-171.
Clin. Cancer Res. MATSUNO F. 371 5 1999
J. Virol. MILLER A.D. 2220 65 1991 10.1128/JVI.65.5.2220-2224.1991
Moritz, D, Wels, W, Mattern, J, Groner, B. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.. Proceedings of the National Academy of Sciences of the United States of America, vol.91, no.10, 4318-4322.
Pardoll, D M. Paracrine Cytokine Adjuvants in Cancer Immunotherapy. Annual review of immunology, vol.13, 399-415.
Pasqualini, Renata, Koivunen, Erkki, Ruoslahti, Erkki. αv Integrins as receptors for tumor targeting by circulating ligands. Nature biotechnology, vol.15, no.6, 542-546.
Cancer Res. RAN S. 4646 58 1998
Robertson, Miranda. Proteasomes in the pathway. Nature, vol.353, no.6342, 300-301.
Schwartzentruber, D J, Hom, S S, Dadmarz, R, White, D E, Yannelli, J R, Steinberg, S M, Rosenberg, S A, Topalian, S L. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.12, no.7, 1475-1483.
Takahashi, Morio, Kawabe, Takao, Ogura, Keiji, Maeda, Shin, Mikami, Yasuyo, Kaneko, Nobuyuki, Terano, Akira, Omata, Masao. Expression of Vascular Endothelial Growth Factor at the Human Gastric Ulcer Margin and in Cultured Gastric Fibroblasts: A New Angiogenic Factor for Gastric Ulcer Healing. Biochemical and biophysical research communications, vol.234, no.2, 493-498.
Oncogene TERMAN B.I. 1677 6 1991
Terman, Bruce I., Dougher-Vermazen, Maureen, Carrion, Miguel E., Dimitrov, Dragan, Armellino, Douglas C., Gospodarowicz, Denis, Böhlen, Peter. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochemical and biophysical research communications, vol.187, no.3, 1579-1586.
Blood TREISMAN J. 139 85 1995 10.1182/blood.V85.1.139.bloodjournal851139
Walter, Elizabeth A., Greenberg, Philip D., Gilbert, Mark J., Finch, Rosalynde J., Watanabe, Käthe S., Thomas, E. Donnall, Riddell, Stanley R.. Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor. The New England journal of medicine, vol.333, no.16, 1038-1044.
J. Immunol. WEIJTENS M.E. 836 157 1996 10.4049/jimmunol.157.2.836
J. Immunol. YEE C. 4079 157 1996 10.4049/jimmunol.157.9.4079
Cancer Res. ZHU Z. 3209 58 1998
Ziegler, B. L., Valtieri, M., Porada, G. Almeida, Maria, R. De, Müller, R., Masella, B., Gabbianelli, M., Casella, I., Pelosi, E., Bock, T., Zanjani, E. D., Peschle, C.. KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells. Science, vol.285, no.5433, 1553-1558.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.